Fig. 4.

Subgroup analyses of 12-week change in a UDysRS total score and b OFF time (2.5 h is the median baseline OFF time). ^a n = 100 for ADS-5102 and 96 for placebo. ^b n = 46 for ADS-5102 and 41 for placebo. ^c n = 54 for ADS-5102 and 55 for placebo. ^d n = 48 for ADS-5102 and 41 for placebo. ^e n = 54 for ADS-5102 and 48 for placebo. ^fMedian value at baseline in the mITT population. ^g n = 46 for ADS-5102 and 40 for placebo. ^h n = 54 for ADS-5102 and 56 for placebo. ⁱ n = 49 for ADS-5102 and 48 for placebo. ^j n = 51 for ADS-5102 and 48 for placebo. ^k n = 45 for ADS-5102 and 49 for placebo. CI confidence interval, LS least squares, MDS–UPDRS Movement Disorder Society–Unified Parkinson’s Disease Rating Scale, UDysRS Unified Dyskinesia Rating Scale